agilon health Q3 revenue up 75% to $1.22B, MA members +58%; lowers FY23 MA membership guidance to 384-386K

agilon health, inc.

Net loss $31M (unchanged YoY); Adj. EBITDA loss $6M vs. $26M loss last year.
Medical margin $108M (+42% YoY) driven by MA growth; core markets excl. Hawaii saw $111M medical margin.
Completed sale of MDX Hawaii (Oct 31) for undisclosed terms; focus on continental US partner markets.
Updated FY23 guidance: MA members 384-386K (down from 412-415K), revenue $4.31-4.32B, adj. EBITDA $6-18M.
ACO REACH contributed $18M to Adj. EBITDA in Q3; expects $39M for FY23 (up from prior $30-35M).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.97

agilon health, inc. reported third quarter ended September 30, 2023 results: revenue $1.22 billion, net income $31 million.

Period: third quarter ended September 30, 2023
Revenue: $1.22 billion
Net income: $31 million
Result: reported results

Exact text from the filing

Total revenue of $1.22 billion increased 75% during the third quarter 2023, compared to $695 million in the third quarter 2022.

View on SEC.gov

Browse all earnings releases →

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-036376

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.